V

VolitionRX Limited
D

VNRX

0.75400
USD
-0.03
(-3.42%)
قبل الجلسة
حجم التداول
58
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
77,679,098
أصول ذات صلة
AAPL
AAPL
1.070
(0.50%)
213.420 USD
AMZN
AMZN
3.150
(1.43%)
223.060 USD
GOOGL
GOOGL
0.720
(0.40%)
179.350 USD
MSFT
MSFT
7.08
(1.44%)
498.10 USD
NFLX
NFLX
10.85
(0.84%)
1,295.48 USD
NVDA
NVDA
2.090
(1.33%)
159.320 USD
PYPL
PYPL
0.230
(0.30%)
76.530 USD
TSLA
TSLA
-1.95
(-0.62%)
313.73 USD
V
V
4.46
(1.26%)
358.67 USD
المزيد
الأخبار المقالات

العنوان: VolitionRX Limited

القطاع: Healthcare
الصناعة: Medical Devices
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.